So this is not the appropriate time ... why not? He did not say there will not be a reverse split so we are still in this uncertainty. I have no idea why we are up 31.85% today. Hopefully there is a good reason.
Theses, with a potential US & European AMD market of $25 to $30B, then throw in the Asian market, along with the SMD market, add in the potential cell-derived platelet market, making ACTC's potential share price, even with the current 2B shares outstanding, huge. And I haven't added in irrational exuberance which always drives the share price much higher than it should be, especially since curing blindness would be a historic medical breakthrough for mankind.
I calculated the the share price for only the US & European AMD market at $22.50 per share, this is a conservative estimate based on revenues of $15B, a 20% profit, and PE = 15.
Now all we need is some great news from ACT to get the ball rolling.